Eva Atsidaftos
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Genetics top 5%
- Blood disorders and treatments
- Hemoglobinopathies and Related Disorders
Papers in
-
- RNA modifications and cancer 26
- Cancer-related gene regulation 22
- Epigenetics and DNA Methylation 12
- RNA and protein synthesis mechanisms 8
- RNA Research and Splicing 1
- Oncology 2
- Peptidase Inhibition and Analysis 2
- Co-authors
- Adrianna Vlachos (26 shared papers)Jeffrey M. Lipton (26 shared papers)Blanche P. Alter (3 shared papers)Philip S. Rosenberg (2 shared papers)Bertil Glader (8 shared papers)Israel Zyskind (1 shared paper)Sarah E. Ball (6 shared papers)Jason E. Farrar (11 shared papers)
- Journals
- Blood (18 papers)The American Journal of Human Genetics (2 papers)Pediatric Blood & Cancer (2 papers)British Journal of Haematology (1 paper)Oncogene (1 paper)
- Partner nations
- United StatesPolandFrance
In The Last Decade
Eva Atsidaftos
26 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 61
- Hematology 251
- Genetics 174
- Molecular Biology 959
- Genetics 286
- Oncology 189
Countries citing papers authored by Eva Atsidaftos
This map shows the geographic impact of Eva Atsidaftos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Atsidaftos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Atsidaftos more than expected).
Fields of papers citing papers by Eva Atsidaftos
This network shows the impact of papers produced by Eva Atsidaftos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Atsidaftos. The network helps show where Eva Atsidaftos may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva Atsidaftos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 330 | |
| 2 | 2012 | 220 | |
| 3 | 2010 | 176 | |
| 4 | 2005 | 137 | |
| 5 | 2012 | 117 | |
| 6 | 2011 | 108 | |
| 7 | 2013 | 85 | |
| 8 | 2001 | 55 | |
| 9 | 2014 | 49 | |
| 10 | 2017 | 22 | |
| 11 | 2021 | 12 | |
| 12 | 2013 | 12 | |
| 13 | 2016 | 10 | |
| 14 | 2006 | 7 | |
| 15 | 2007 | 7 | |
| 16 | 2008 | 6 | |
| 17 | 2010 | 6 | |
| 18 | 2010 | 6 | |
| 19 | 2009 | 6 | |
| 20 | 2009 | 5 |
About Eva Atsidaftos
Eva Atsidaftos is a scholar working on Molecular Biology, Oncology, Cancer Research, Surgery and Genetics, having authored 27 papers that have together received 1.4k indexed citations. Recurring topics across this work include RNA modifications and cancer (26 papers), Cancer-related gene regulation (22 papers), Epigenetics and DNA Methylation (12 papers), RNA and protein synthesis mechanisms (8 papers), Peptidase Inhibition and Analysis (2 papers), RNA Research and Splicing (1 paper), Protease and Inhibitor Mechanisms (1 paper) and Tissue Engineering and Regenerative Medicine (1 paper). The work is most often cited by research in Hematology (251 citations), Genetics (174 citations), Molecular Biology (959 citations), Genetics (286 citations) and Oncology (189 citations). Eva Atsidaftos has collaborated with scholars based in United States, Poland and France. Frequent co-authors include Adrianna Vlachos, Jeffrey M. Lipton, Blanche P. Alter, Philip S. Rosenberg, Bertil Glader, Israel Zyskind, Sarah E. Ball, Jason E. Farrar, R.J. Arceci and Hanna T. Gazda. Their work appears in journals such as Blood, The American Journal of Human Genetics, Pediatric Blood & Cancer, British Journal of Haematology and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.